{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T03:00:24Z","timestamp":1769914824864,"version":"3.49.0"},"reference-count":14,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100012781","name":"Merck Sharp and Dohme K.K.","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012781","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","jiac-j.com","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Chemotherapy"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.jiac.2024.11.019","type":"journal-article","created":{"date-parts":[[2024,12,2]],"date-time":"2024-12-02T16:36:55Z","timestamp":1733157415000},"page":"102569","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Tazobactam\/ceftolozane (TAZ\/CTLZ) and relebactam\/imipenem (REL\/IPM) susceptibility in Japan: Nationwide surveillance of respiratory bacterial pathogens in 2019\/20"],"prefix":"10.1016","volume":"31","author":[{"given":"Katsunori","family":"Yanagihara","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0319-3958","authenticated-orcid":false,"given":"Dai","family":"Kurihara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5528-3368","authenticated-orcid":false,"given":"Masahiro","family":"Kimata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"18","key":"10.1016\/j.jiac.2024.11.019_bib1","doi-asserted-by":"crossref","first-page":"3472","DOI":"10.1016\/j.jmb.2019.04.002","article-title":"\u03b2-Lactamases and \u03b2-lactamase inhibitors in the 21st century","volume":"431","author":"Tooke","year":"2019","journal-title":"J Mol Biol"},{"key":"10.1016\/j.jiac.2024.11.019_bib2","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02318-20","article-title":"New perspectives on antimicrobial agents: ceftolozane-tazobactam","volume":"65","author":"Lizza","year":"2021","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiac.2024.11.019_bib3","article-title":"Lodise New perspectives on antimicrobial agents: imipenem-relebactam","volume":"66","author":"O'Donnell","year":"2022","journal-title":"Antimicrob Agents Chemother"},{"issue":"8","key":"10.1016\/j.jiac.2024.11.019_bib4","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/j.jiac.2023.04.008","volume":"29","author":"Tokimatsu","year":"2023","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.jiac.2024.11.019_bib5","series-title":"Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically","year":"2018"},{"key":"10.1016\/j.jiac.2024.11.019_bib6","series-title":"Performance standards for antimicrobial susceptibility testing (CLSI M100","year":"2021"},{"issue":"2","key":"10.1016\/j.jiac.2024.11.019_bib7","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.02235-21","article-title":"In vitro antibacterial activity of imipenem\/relebactam against clinical isolates in Japan","volume":"10","author":"Kurihara","year":"2022","journal-title":"Microbiol Spectr"},{"issue":"3","key":"10.1016\/j.jiac.2024.11.019_bib8","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1093\/jac\/dkp498","article-title":"Development of a set of multiplex PCR assays for the detection of genes encoding important beta-lactamases in Enterobacteriaceae","volume":"65","author":"Dallenne","year":"2010","journal-title":"J Antimicrob Chemother"},{"issue":"12","key":"10.1016\/j.jiac.2024.11.019_bib9","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1093\/cid\/ciy378","article-title":"Difficult-to-Treat resistance in gram-negative bacteremia at 173 US hospitals: retrospective cohort analysis of prevalence, predictors, and outcome of resistance to all first-line agents","volume":"67","author":"Kadri","year":"2018","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2024.11.019_bib10","article-title":"Infectious diseases society of America 2023 guidance on the treatment of antimicrobial resistant gram-negative infections","volume":"18","author":"Tamma","year":"2023","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.jiac.2024.11.019_bib11","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1128\/CMR.00040-06","article-title":"Antimicrobial resistance in Haemophilus influenzae","volume":"20","author":"Tristram","year":"2007","journal-title":"Clin Microbiol Rev"},{"issue":"5","key":"10.1016\/j.jiac.2024.11.019_bib12","doi-asserted-by":"crossref","first-page":"e00211","DOI":"10.1128\/AAC.00211-20","article-title":"Antimicrobial activity of ceftolozane-tazobactam and comparators against clinical isolates of Haemophilus influenzae from the United States and europe","volume":"64","author":"Sader","year":"2020","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"10.1016\/j.jiac.2024.11.019_bib13","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.02579-21","article-title":"Antimicrobial susceptibility survey of invasive Haemophilus influenzae in the United States in 2016","volume":"10","author":"Potts","year":"2022","journal-title":"Microbiol Spectr"},{"issue":"6","key":"10.1016\/j.jiac.2024.11.019_bib14","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1093\/jac\/dkaa049","article-title":"Lung penetration, bronchopulmonary pharmacokinetic\/pharmacodynamic profile and safety of 3 g of ceftolozane\/tazobactam administered to ventilated, critically ill patients with pneumonia","volume":"75","author":"Caro","year":"2020","journal-title":"J Antimicrob Chemother"}],"container-title":["Journal of Infection and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X24003167?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X24003167?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,6]],"date-time":"2025-03-06T16:01:42Z","timestamp":1741276902000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1341321X24003167"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":14,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["S1341321X24003167"],"URL":"https:\/\/doi.org\/10.1016\/j.jiac.2024.11.019","relation":{},"ISSN":["1341-321X"],"issn-type":[{"value":"1341-321X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tazobactam\/ceftolozane (TAZ\/CTLZ) and relebactam\/imipenem (REL\/IPM) susceptibility in Japan: Nationwide surveillance of respiratory bacterial pathogens in 2019\/20","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Chemotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jiac.2024.11.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Japanese Society of Chemotherapy, Japanese Association for Infectious Diseases, and Japanese Society for Infection Prevention and Control. Published by Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102569"}}